chr18-45734273-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 7P and 1B. PVS1_StrongPP3PP5_ModerateBS2_Supporting
The ENST00000321925.9(SLC14A1):c.342-1G>A variant causes a splice acceptor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00024 in 1,613,980 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
ENST00000321925.9 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC14A1 | NM_015865.7 | c.342-1G>A | splice_acceptor_variant | ENST00000321925.9 | NP_056949.4 | |||
LOC105372093 | XR_935423.3 | n.826+3193C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC14A1 | ENST00000321925.9 | c.342-1G>A | splice_acceptor_variant | 1 | NM_015865.7 | ENSP00000318546 | P1 | |||
ENST00000589510.5 | n.160+3193C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000454 AC: 69AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000819 AC: 206AN: 251418Hom.: 1 AF XY: 0.000817 AC XY: 111AN XY: 135882
GnomAD4 exome AF: 0.000218 AC: 318AN: 1461768Hom.: 7 Cov.: 32 AF XY: 0.000197 AC XY: 143AN XY: 727182
GnomAD4 genome AF: 0.000460 AC: 70AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74418
ClinVar
Submissions by phenotype
Jk-null variant Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | May 22, 1998 | - - |
SLC14A1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2023 | The SLC14A1 c.342-1G>A variant is predicted to disrupt the AG splice acceptor site and interfere with normal splicing. This variant is predicted to disrupt the consensus AG splice-acceptor site in SLC14A1 near the intron 4 – exon 5 boundary and has been reported in affected individuals (Lucien et al. 1998. PubMed ID: 9582331; Hou et al. 2020. PubMed ID: 31980526). SLC14A1 encodes a urea transporter that is found in the kidney and on red blood cells. The blood type Jk-null is defined by a loss of the SLC14A1 protein on red blood cells. The Jk-null blood type is not defined by any obvious clinical presentation, but patients may have a urine concentration defect (Sands et al. 1992. PubMed ID: 1498276). Patients with two deleterious variants in a trans configuration may have the Jk-null phenotype and could develop alloantibodies against the Jk antigen during pregnancy or after transfusion with Jk+ red blood cells that may cause hemolysis (Lucien et al. 2002. PubMed ID: 11807016). This variant is reported in 1.1% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-43314238-G-A). Variants that disrupt the consensus splice acceptor site in SLC14A1 are expected to be pathogenic. This variant is interpreted as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at